Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000878987 | SCV001021994 | likely benign | Glycogen storage disease, type VII | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000878987 | SCV003814897 | uncertain significance | Glycogen storage disease, type VII | 2023-11-21 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV004792567 | SCV005408318 | uncertain significance | not provided | 2024-07-22 | criteria provided, single submitter | clinical testing | BP4_moderate |
Natera, |
RCV000878987 | SCV001459560 | uncertain significance | Glycogen storage disease, type VII | 2020-01-24 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003948282 | SCV004765717 | likely benign | PFKM-related disorder | 2023-06-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |